Wealth Science Advisors’s Clorox CLX Stock Holding History

Wealth Science Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,248	Closed	-$126K	–	115
2026 Q1	$126K	Buy	+1,248	New	+$141K	0.07%	81

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wealth Science Advisors's CLX Position: Q2 2026 in Review

Wealth Science Advisors sold out of Clorox (CLX) in Q2 2026, closing a stake of 1,248 shares — an estimated $126K sold.

Wealth Science Advisors first reported a position in CLX in Q1 2026 and held it in 1 quarter. The position peaked at $126K in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Wealth Science Advisors reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
Wealth Science Advisors sold 1,248 Clorox shares in Q2 2026, an estimated $126K.
Wealth Science Advisors first reported a position in Clorox in Q1 2026 and held it in 1 quarter.
Wealth Science Advisors's Clorox position peaked at $126K in Q1 2026.
1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.